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Since 1994, four cases of epidermal nevus with epidermolytic hyperkeratosis (EH) caused by keratin 10 gene
mutations have been reported, although no keratin 1 (K1) gene mutation has yet been reported. We detected a
K1 gene (KRT1) mutation in epidermal nevus with EH in a 10-year-old Japanese male. The patient showed well-
demarcated verrucous, hyperkeratotic plaques mainly on the trunk, covering 15% of the entire body surface. No
hyperkeratosis was seen on the palms or soles. He had no family history of skin disorders. His lesional skin
showed typical granular degeneration and, ultrastructurally, clumped keratin filaments were observed in the
upper epidermis. Direct sequence analysis of genomic DNA extracted from lesional skin revealed a
heterozygous 50 donor splice site mutation c.591þ 2T4A in KRT1. This mutation was not detected in genomic
DNA samples from the patient’s peripheral blood leukocytes or those of other family members. The identical
splice mutation was previously reported in a family with palmoplantar keratoderma and mild ichthyosis, and
was demonstrated to result in a 22 amino-acid deletion p.Val175_Lys196del in the H1 and 1A domains of K1. To
our knowledge, the present patient is the first reported case of epidermal nevus associated with EH caused by a
K1 gene mutation in a mosaic pattern.
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INTRODUCTION
Epidermal nevi are skin hamartomatous lesions comprised of
keratinocytes. Their clinical features include circumscribed
verrucous lesions of any size, single or multiple in nature, and
they can occur at any site, frequently following Blaschko’s
lines. Epidermal nevi are thought to reflect a genetic
mosaicism, and it has been often hypothesized that epider-
mal nevi with epidermolytic hyperkeratosis (EH) reflect
differentiation specific, suprabasal keratin gene mutations.
The term ‘‘EH’’ in this case means pathological changes seen
in bullous congenital ichthyosiform erythroderma, a keratin 1
(K1)/keratin 10 (K10) disease, although EH is a histological
feature of more than one disease. Indeed, K10 gene mutations
were reported in four cases of epidermal nevi with EH (Paller
et al., 1994; Moss et al., 1995), although no K1 gene mutation
has yet been reported. A mosaic mutation in the V1 domain
of keratin 16 was reported to underlie unilateral palmoplantar
verrucous nevus with vacuolar degeneration of keratinocytes
in the upper epidermis (Terrinoni et al., 2000).
A diverse range of subtly different phenotypes including
classical bullous congenital ichthyosiform erythroderma has
been described with mutations in K1 (reviewed by Lane and
McLean, 2004). Splice site mutations affecting the K1 peptide
1A or 2B domain caused epidermolytic palmoplantar
keratoderma (PPK) (reviewed by Terron-Kwiatkowski et al.,
2002). Now a total of 47 different mutations have been
reported in K1 (The Human Intermediate Filament Database).
Here we report that a splice site mutation in the K1 gene,
previously reported in a case of PPK and mild ichthyosis, was
associated with the epidermal nevus with EH disease
phentoype. As far as we know, the present case is the first
reported patient of epidermal nevus with EH associated with
a K1 gene mutation.
RESULTS
Clinical features
A 10-year-old Japanese male showed well-demarcated
verrucous, hyperkeratotic plaques mainly on the trunk,
covering 15% of his entire body surface. They distributed
following the Blaschko’s lines (Figure 1). No hyperkeratosis
was seen on the palms and soles. The other family members
including his parents and elder brother had neither bullous
congenital ichthyosiform erythroderma nor epidermal nevus.
Typical granular degeneration and clumped keratin filaments
were seen in the epidermal nevus
Light microscopy of the skin samples from the nevus on the
trunk revealed typical granular degeneration with large
keratohyalin granules in the upper epidermis (data not
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shown). Electron microscopy showed clumped keratin
filaments in the upper epidermal keratinocytes (data not
shown). Some of those keratinocytes with abnormal keratin
clumps were undergoing degeneration.
A splice site mutation in K1 gene (KRT1) was identified in
lesional skin but not in peripheral blood
Mutation analysis of the entire 1–9 exons including the
intron–exon boundaries of the K1 gene (KRT1) revealed a
heterozygous T4A substitution at base position 591þ2, in
intron 1 (c.591þ 2T4A). (Figure 2). This mutation disrupts
the KRT1 exon 1 donor splice site. This mutation was not
detected in genomic DNA samples from patient’s peripheral
blood leukocytes (Figure 2a) or those of his family members.
No other mutation was found in the entire exon and intron/
exon borders of the K1 and K10 genes. The mutation was not
found in 100 normal, unrelated Japanese alleles (50 healthy
unrelated Japanese individuals) by sequence analysis, and
was unlikely to be a polymorphism (data not shown).
By mutant allele-specific amplification analysis (Hasegawa
et al., 1995; Xu et al., 2003), a 102-bp fragment derived from
the mutant allele was amplified from the genomic DNA
sample extracted from the lesional skin (Figure 2b). The
102-bp fragment was sequenced and it was confirmed that
the fragment was derived from the targeted region of K1
gene, KRT1. The mutant allele-specific amplification showed
no PCR product bands from the peripheral blood cell DNA
samples from the patient, any other family members or
controls.
K1 expression was weak and keratin 2e (K2e) expression was
upregulated in the epidermal nevus lesion
Immunofluorescence studies revealed that K1 and K10 were
present in the lesional epidermal suprabasal layers, although
K1 expression was weaker than that in the normal control
skin (Figure S1a–d). In the regions showing granular
degeneration, abnormal, large granules in the degenerated
keratinocytes were positive for K1 and K10. K2e was
expressed only in the uppermost spinous and the granular
layers of epidermis in normal control skin (Figure S1f). In the
patient’s lesional skin, K2e expression was seen in the almost
all suprabasal epidermal layers, suggesting an upregulated
expression of K2e in the lesional epidermis (Figure S1e).
DISCUSSION
All the reported causative mutations underlying epidermal
nevus with EH affected the K10 gene (Paller et al., 1994;
Moss et al., 1995). As far as we know, the present case is the
first reported case of epidermal nevus with EH caused by a K1
gene mutation.
K2e expression increased in the lesional epidermis of the
present case. Although we do not have any direct evidence,
K2e expression might be upregulated compensatively in the
epidermis with disrupted keratin network. Indeed, increased
K2e expression was also observed in the lesional epidermis
with disturbed keratin network of ichthyosis bullosa of
Siemens patients (Akiyama et al., 2005).
In our case, the causative K1 mutation was detected only
in the lesional skin, but not in the peripheral blood cells, as
previously reported in K10 mutations in epidermal nevus
with EH (Paller et al., 1994; Moss et al., 1995). Our findings
further support that the mutation detection of K1 as well as
K10 in epidermal nevus can be reliably performed only from
direct examination of lesional skin, not from analysis of other
tissue or peripheral blood cells.
As epidermal nevus is a disease caused by somatic
mosaicism, widespread skin lesions increase the risk of
germ-line transmission (Paller et al., 1994). In case causative
K1 or K10 mutations are transmitted in germ-line, a half of the
children from patients with epidermal nevus with EH are
expected to be affected with ichthyosis on the whole body.
Mutation analysis using a patient’s sperm gives us informa-
tion on germ-line transmission (Zlotogora, 1998; Rantamaki
et al., 1999). If the germ-line transmission is confirmed,
prenatal genetic screening may be applied for the offspring of
a b c
Figure 1. Clinical features of epidermal nevi at the age of 10. Well-
demarcated verrucous, hyperkeratotic plaques, light to dark brown in color,
were seen on the (a) back, (b) axilla, and (c) abdomen.
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Figure 2. A splice site mutation c.591þ 2T4A was detected in the lesional
skin. (a) Direct sequencing of KRT1 exon 1 PCR products derived from
patient’s lesional skin revealed heterozygous donor splice site mutation
c.591þ 2T4A. This mutation was not detected in genomic DNA samples
from the patient’s peripheral blood leukocytes. (b) Mutant allele-specific
amplification analysis showed the amplification band from the mutant allele
as a 102-bp fragment only from the DNA sample from the patient’s lesional
skin, confirming the presence of the mutation c.591þ2T4A in the patient’s
epidermal nevus.
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the patient as previously reported in the prenatal diagnosis of
bullous congenital ichthyosiform erythroderma by molecular
analysis (Rothnagel et al., 1994; Tsuji-Abe et al., 2004).
The K1 gene mutation detected in the present case was a
splice donor site mutation c.591þ 2T4A. According to
Splice Site Prediction by Neural Network software (http://
www.fruitfly.org/seq_tools/splice.html) (Tal et al., 2005;
Wessagowit et al., 2005, 2006), a consequence of this
mutation is predicted with the highest probability, we can
expect a splice variant with an upstream cryptic splice donor
site resulting in a 66 bp deletion (22 amino-acid deletion;
p.Val175-Lys196del). The second highest probability, an
alternative splice pattern activating a cryptic donor site 22 bp
downstream of the mutation with the subsequent insertion of
eight amino acids into the 1A rod domain was predicted.
Indeed, in a patient with PPK with the same K1 gene mutation
as in the present case, messenger RNA expression analysis by
in vitro splicing assay clearly indicated that the splice site
mutation c.591þ2T4A results in a partial deletion of the H1
and 1A domains of K1 (p.Val175_Lys196del) (Terron-
Kwiatkowski et al., 2002), as predicted by the highest
probability using the software model. Concerning reported
mutations in the adjacent nucleotide as our mutation in the
K1 gene, that is, splice donor site mutations c.591þ1G4A,
G4C and c.591þ3G4T were reported to lead to the same
22 amino-acid deletions (Vitanen et al., 2003; Tal et al.,
2005). Thus, we may expect an identical 22 amino-acid
deletion p.Val175_Lys196del in K1 peptides as a conse-
quence of the KRT1 mutation c.591þ 2T4A in lesional
keratinocytes from the present patient.
Interestingly, the KRT1 mutation that had been reported to
cause PPK (Terron-Kwiatkowski et al., 2002) led to an
epidermal nevus with EH phenotype distributed on the trunk
and the extremities in our case. In the previous PPK patient
with an identical mutation, only mild hyperkeratosis was
found over limited body areas and it was speculated that loss
of the protein motif in the helix boundary that is essential for
the interaction of keratin filaments (Steinert et al., 1993) have
a less disruptive effect on normal keratin filament assembly
(Terron-Kwiatkowski et al., 2002). A similar mechanism can
be expected in deletions at either end of the K1 rod domain.
Indeed, a splice site mutation in K1 that leads to the
insertion of 18 amino acids into the 2B domain led to a mild
epidermolytic PPK phenotype (reviewed by Terron-
Kwiatkowski et al., 2002). However, in our case, the
mosaicism of the mutation showed an epidermal nevus
phenotype even on the trunk and the extremities. The precise
mechanism of how identical splice site mutations can result in
a different severity of the lesions on the trunk remains unclear.
Until the present report, all the reported mosaic mutations
causing epidermal nevus with EH had been owing to K10
mutations that would have resulted in bullous congenital
ichthyosiform erythroderma if every cell in the body were
affected (Paller et al., 1994; Moss et al., 1995). In conclusion,
the present case clearly indicated that K1 mutations with
genetic mosaicism also cause epidermal nevus with EH. The
present K1 mosaicism might have led to PPK with mild
hyperkeratotic lesions if all the epidermal cells were affected
over the entire body surface (Terron-Kwiatkowski et al.,
2002).
MATERIALS AND METHODS
Mutation detection
Mutation analysis was performed using genomic DNA extracted
from the lesional epidermal nevus skin and peripheral blood
leukocytes from the patient. In the other family members and
normal controls, genomic DNA isolated from peripheral blood
leukocytes was used for the analysis. Briefly, genomic DNA samples
were subjected to PCR amplification, followed by direct automated
sequencing using an ABI PRISM 3100 genetic analyzer (ABI
Advanced Biotechnologies, Columbia, MD). The oligonucleotide
primers were designed using the website program (primer3_www.
cgi v 0.2). The primers used for amplification of exon 1 were as
follows; forward, gtggacgtggtagtggcttt; reverse, ctttaggtcgaccaccaacc.
The entire coding region including the intron/exon boundaries for
both forward and reverse strands were sequenced. For normal
controls, 50 healthy unrelated Japanese individuals (100 normal
alleles) were studied.
Mutant allele-specific amplification analysis
Long and accurate PCR was carried out using primers, forward
primer ex1F1; aggaggtgggagatttt and a reverse primer ex2R;
catgctgcttcatgatcttagc. For the verification of the mutation, using
long and accurate PCR products as a template, mutant allele-specific
amplification analysis was performed with mutant allele-specific
primers carrying the substitution of two bases at the 30-end (Linard
et al., 2002; Sapio et al., 2006), as follows; forward, gcctccttcattga-
caagaa; reverse, ttcaaacctgcgtgtgttttgactgcaccgatccc. PCR conditions
were as follows; 941C for 5 minutes after (hot-start procedure) and
then 941C for 1 minute, 561C for 1 minute, 721C for 1 minute during
35 cycles, and followed by 721C for 7 minutes. Only the 102-bp
fragment derived from the mutant allele was amplified with these
primers and the PCR condition.
Ultrastructural observations
Epidermal nevus on the trunk was biopsied for morphological
observation. Skin biopsy samples were fixed in 2% glutaraldehyde
solution, post-fixed in 1% OsO4, dehydrated, and embedded in
Epon 812. The samples were sectioned at 1mm thickness for light
microscopy and thin sectioned for electron microscopy (70 nm
thick). The thin sections were stained with uranyl acetate and lead
citrate and examined in a transmission electron microscope.
Antibodies
Polyclonal anti-K1 antiserum (DAKO, Glostrup, Denmark), anti-K2e
antibody (Progen Biotechnick, Heidelberg, Germany) and anti-K10
antiserum (Novocastra, New Castle upon Tyne, England) were used
in this study.
Immunofluorescent labeling
Immunofluorescent labeling was performed as described previously
(Akiyama et al., 2000). Briefly, 6-mm-thick sections of freshly frozen
patient’s skin was cut using a cryostat. The sections were incubated
in primary antibody solution for 30 minutes at 371C. Antibody
dilutions were as follows; 1/10 for anti-K1 antiserum, 1/50 for anti-
K2e antibody, and 1/100 for anti-K10 antibody. The sections were
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then incubated in FITC-conjugated to rabbit anti-mouse Igs and
FITC-conjugated goat anti-mouse Igs diluted 1:100 (DAKO) for
30 minutes at 371C. The sections were extensively washed with
phosphate-buffered saline between incubations. The stained sections
were then mounted with a coverslip and observed using a confocal
laser scanning microscope.
The medical ethical committee at Hokkaido University and
Hokkaido Cancer Institute approved all described studies. The study
was conducted according to the Declaration of Helsinki Principles.
Participants gave their written, informed consent.
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SUPPLEMENTARY MATERIAL
Figure S1. Immunofluorescent staining for K1 was weak, although K2e
expression was upregulated in the epidermal nevus.
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